Hsp90 inhibitors: small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradation, Med. Res. Rev, pp.26-310, 2006. ,
Novobiocin and additional inhibitors of the Hsp90 Cterminal nucleotide-binding pocket, Curr. Med. Chem, pp.15-2702, 2008. ,
Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?, Clinical Cancer Research, vol.18, issue.1, pp.64-76, 2012. ,
DOI : 10.1158/1078-0432.CCR-11-1000
Inhibiting HSP90 to Treat Cancer: A Strategy in Evolution, Current Molecular Medicine, vol.12, issue.9, pp.12-1108, 2012. ,
DOI : 10.2174/156652412803306657
To fold or not to fold: modulation and consequences of Hsp90 inhibition, Future Medicinal Chemistry, vol.1, issue.2, 2009. ,
DOI : 10.4155/fmc.09.17
Inhibitors of the Hsp90 C-terminus, Inhibitors of Molecular Chaperones as Therapeutic Agents ,
Novobiocin and Related Coumarins and Depletion of Heat Shock Protein 90-Dependent
Signaling Proteins, JNCI: Journal of the National Cancer Institute, vol.92, issue.3, pp.92-242, 2000. ,
DOI : 10.1093/jnci/92.3.242
Structural Basis for Inhibition of the Hsp90 Molecular Chaperone by the Antitumor Antibiotics Radicicol and Geldanamycin, Journal of Medicinal Chemistry, vol.42, issue.2, p.42, 1999. ,
DOI : 10.1021/jm980403y
Modulation of Chaperone Function and Cochaperone Interaction by Novobiocin in the C-terminal Domain of Hsp90, Journal of Biological Chemistry, vol.281, issue.11, pp.281-7161, 2006. ,
DOI : 10.1074/jbc.M512406200
Hsp90 Inhibitors Identified from a Library of Novobiocin Analogues, Journal of the American Chemical Society, vol.127, issue.37, pp.12778-12779, 2005. ,
DOI : 10.1021/ja0535864
Development of Novobiocin Analogues That Manifest Anti-proliferative Activity against Several Cancer Cell Lines, The Journal of Organic Chemistry, vol.73, issue.6, pp.73-2130, 2008. ,
DOI : 10.1021/jo702191a
Engineering an Antibiotic to Fight Cancer: Optimization of the Novobiocin Scaffold to Produce Anti-proliferative Agents, Journal of Medicinal Chemistry, vol.54, issue.11, p.54, 2011. ,
DOI : 10.1021/jm200148p
Synthesis and Evaluation of Noviose Replacements on Novobiocin That Manifest Antiproliferative Activity, ACS Medicinal Chemistry Letters, vol.1, issue.7, pp.311-315, 2010. ,
DOI : 10.1021/ml100070r
Novobiocin analogues with second-generation noviose surrogates, Bioorganic & Medicinal Chemistry Letters, vol.23, issue.2, pp.552-557, 2013. ,
DOI : 10.1016/j.bmcl.2012.11.022
3D-QSAR-Assisted Design, Synthesis, and Evaluation of Novobiocin Analogues, ACS Medicinal Chemistry Letters, vol.4, issue.1, pp.57-62, 2013. ,
DOI : 10.1021/ml300275g
Identification of a New Scaffold for Hsp90 C-Terminal Inhibition, ACS Medicinal Chemistry Letters, vol.5, issue.1, pp.84-88, 2014. ,
DOI : 10.1021/ml400404s
Design, synthesis and biological evaluation of biphenylamide derivatives as Hsp90??C-terminal inhibitors, European Journal of Medicinal Chemistry, vol.89, pp.442-466, 2015. ,
DOI : 10.1016/j.ejmech.2014.10.034
Design, Synthesis, and Biological Evaluation of Ring-Constrained Novobiocin Analogues as Hsp90 C-Terminal Inhibitors, ACS Medicinal Chemistry Letters, vol.6, issue.2, 2015. ,
DOI : 10.1021/ml5004475
New novobiocin analogues as antiproliferative agents in breast cancer cells and potential inhibitors of heat shock protein 90, J. Med. Chem, pp.50-6189, 2007. ,
Antiproliferative and apoptotic activities of tosylcyclonovobiocic acids as potent heat shock protein 90 inhibitors in human cancer cells, Cancer Letters, vol.274, issue.1, pp.88-94, 2009. ,
DOI : 10.1016/j.canlet.2008.09.001
Discovery and Biological Activity of 6BrCaQ as an Inhibitor of the Hsp90 Protein Folding Machinery, ChemMedChem, vol.306, issue.5, pp.804-816, 2011. ,
DOI : 10.1002/cmdc.201000489
Synthesis and antiproliferative activity of novobiocin analogues as potential hsp90 inhibitors, Synthesis and antiproliferative activity of novobiocin analogues as potential Hsp90 inhibitors, pp.498-507, 2014. ,
DOI : 10.1016/j.ejmech.2014.06.067
Divergent route to access structurally diverse 4- quinolones via mono or sequential cross-couplings, J. Org. Chem, pp.75-8654, 2010. ,
Differential functionalization of 1,6-naphthyridin-2(1H)-ones through sequential one-pot Suzuki-Miyaura cross couplings, Eur. J. Org. Chem, vol.7, pp.1487-1495, 2014. ,
Efficient one-pot synthesis of 3,7-disubstituted 1,6-naphthyridin-2(1H)-ones through regioselective palladium-catalyzed cross-coupling and SNAr reactions, Tetrahedron, vol.71, 2015. ,
Vi~ na, 3-Amidocoumarins as potential multifunctional agents against neurodegenerative diseases, ChemMedChem, vol.10, 2015. ,
Isoquinoline derivatives as inhibitors of rho-kinase, PCT Int, Appl. WO, 2005. ,
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors, Nature, vol.425, issue.6956, pp.425-407, 2003. ,
DOI : 10.1038/nature01913
Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo, BMC Cancer, vol.79, issue.1, p.276, 2010. ,
DOI : 10.1002/(SICI)1097-0215(19981023)79:5<468::AID-IJC4>3.0.CO;2-Z
First gallaminetacrine hybrid: design and characterization at cholinesterases and the M2 muscarinic receptor, J. Med. Chem, pp.50-5685, 2007. ,
General catalysts for the Suzuki-Miyaura and Sonogashira coupling reactions of aryl chlorides and for the coupling of challenging substrate combinations in water, Angew. Chem. Int. Ed, pp.44-6173, 2005. ,